(c) 2024 PillSync.com

methylphenidate hydrochloride tablet methylphenidate hydrochloride tablet extended release

1 INDICATIONS AND USAGE Methylphenidate hydrochloride tablets are indicated for the treatment of: Attention Deficit Hyperactivity Disorders (ADHD) in pediatric patients 6 years and older and adults Narcolepsy Methylphenidate hydrochloride is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorders (ADHD) and Narcolepsy ( 1 ).

specgx llc


5 years ago ROUND WHITE M 1423 methylphenidate hydrochloride tablet methylphenidate hydrochloride tablet extended release

ROUND WHITE M 1423

16 HOW SUPPLIED/STORAGE AND HANDLING

METHYLPHENIDATE HYDROCHLORIDE Tablets USP 5 mg tablets available as a round, white unscored tablet debossed with 5 on one side and a on the other side Bottles of 100........................NDC 0406-1142-01 10 mg tablets available as a round, white scored tablet debossed with 10 on one side of the tablet and a M on the other side Bottles of 100........................NDC 0406-1144-01 20 mg tablets available as a round, white scored tablet debossed with 20 on one side of the tablet and a on the other side Bottles of 100........................NDC 0406-1146-01 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Dispense in tight, light-resistant container with child-resistant closure. Note :

METHYLPHENIDATE HYDROCHLORIDE tablets are color-additive free. Boxed M Boxed M


More pills like ROUND M 1423












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site